Northwestern Mutual Wealth Management’s Cocrystal Pharma COCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$858 Hold
817
﹤0.01% 3815
2026
Q1
$825 Hold
817
﹤0.01% 3784
2025
Q4
$800 Hold
817
﹤0.01% 3668
2025
Q3
$1.02K Hold
817
﹤0.01% 3540
2025
Q2
$1.22K Hold
817
﹤0.01% 3356
2025
Q1
$1.16K Hold
817
﹤0.01% 3255
2024
Q4
$1.65K Hold
817
﹤0.01% 3218
2024
Q3
$1.44K Buy
+817
New +$1.59K ﹤0.01% 3186

Other funds holding COCP

Northwestern Mutual Wealth Management's COCP Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Cocrystal Pharma (COCP) position steady in Q2 2026 at 817 shares worth $858. The position accounts for ﹤0.01% of the portfolio, ranked #3815.

Northwestern Mutual Wealth Management first reported a position in COCP in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.65K in Q4 2024. 27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • Northwestern Mutual Wealth Management held 817 shares of Cocrystal Pharma worth $858 as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Cocrystal Pharma share count unchanged in Q2 2026.
  • Cocrystal Pharma made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3815 holding.
  • Northwestern Mutual Wealth Management first reported a position in Cocrystal Pharma in Q3 2024 and has held it in 8 quarters since.
  • Northwestern Mutual Wealth Management's Cocrystal Pharma position peaked at $1.65K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.